Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noteableon Nov 28, 2022 4:34pm
164 Views
Post# 35134968

RE:RE:RE:RE:RE:RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stock

RE:RE:RE:RE:RE:RE:RE:RE:Tactics used x Hedge Fund & MM to acquire shareholder stockYet another sign that the share price is being manipulated is when you have posters claim that they have owned the stock for XX years but then begin to manipulatively crticize the same stock throwing around phrases such as "no proof" of efficacy and "anemic volume" of trades in the stock. etc. etc.

If the poster Quention aka Uber wasn't so deeply conflicted in his on-liine presense, one could correctly assume that this poster was intent on manipulating the price of this stock at any expense. And his manipulative criticism is not for the sake of caution, as he tries to portray ... it is rather to keep buyers on the side-line as he continues his opaque work at trying to contradict what ONCY has demonstrated in IND-213 and then AWARE-1 and now Goblet and soon Bracelet-1 clinical studies.

Quentin aka Uber has also tried to cast a manipulative shadow over ONCY's stated and implied plans leading to the approval of pelareorep, whether it is a Phase III registration study OR an accelerated approval that can eqully occur. Whichever the pathway ONCY has its sights on Big Pharma as an exit strategy.


<< Previous
Bullboard Posts
Next >>